These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

393 related items for PubMed ID: 25929843

  • 1. Dose-level response rates of mTor inhibition in tuberous sclerosis complex (TSC) related subependymal giant cell astrocytoma (SEGA).
    Weidman DR, Pole JD, Bouffet E, Taylor MD, Bartels U.
    Pediatr Blood Cancer; 2015 Oct; 62(10):1754-60. PubMed ID: 25929843
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Factors affecting response to everolimus therapy for subependymal giant cell astrocytomas associated with tuberous sclerosis.
    Trelinska J, Dachowska I, Kotulska K, Baranska D, Fendler W, Jozwiak S, Mlynarski W.
    Pediatr Blood Cancer; 2015 Apr; 62(4):616-21. PubMed ID: 25557360
    [Abstract] [Full Text] [Related]

  • 5. [Response to everolimus in patients with giant cell astrocytoma associated to tuberous sclerosis complex].
    Mateos-González ME, López-Laso E, Vicente-Rueda J, Camino-León R, Fernández-Ramos JA, Baena-Gómez MA, Peña-Rosa MJ.
    Rev Neurol; 2014 Dec 01; 59(11):497-502. PubMed ID: 25418144
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. The effect of mTOR inhibition on obstructive hydrocephalus in patients with tuberous sclerosis complex (TSC) related subependymal giant cell astrocytoma (SEGA).
    Weidman DR, Palasamudram S, Zak M, Whitney R, McCoy B, Bouffet E, Taylor M, Shroff M, Bartels U.
    J Neurooncol; 2020 May 01; 147(3):731-736. PubMed ID: 32285309
    [Abstract] [Full Text] [Related]

  • 8. Long-term effect of everolimus on epilepsy and growth in children under 3 years of age treated for subependymal giant cell astrocytoma associated with tuberous sclerosis complex.
    Kotulska K, Chmielewski D, Borkowska J, Jurkiewicz E, Kuczyński D, Kmieć T, Łojszczyk B, Dunin-Wąsowicz D, Jóźwiak S.
    Eur J Paediatr Neurol; 2013 Sep 01; 17(5):479-85. PubMed ID: 23567018
    [Abstract] [Full Text] [Related]

  • 9. Presurgical Administration of mTOR Inhibitors in Patients with Large Subependymal Giant Cell Astrocytoma Associated with Tuberous Sclerosis Complex.
    Jiang T, Du J, Raynald, Wang J, Li C.
    World Neurosurg; 2017 Nov 01; 107():1053.e1-1053.e6. PubMed ID: 28866062
    [Abstract] [Full Text] [Related]

  • 10. Management of subependymal giant cell astrocytoma (SEGA) associated with tuberous sclerosis complex (TSC): Clinical recommendations.
    Jóźwiak S, Nabbout R, Curatolo P, participants of the TSC Consensus Meeting for SEGA and Epilepsy Management.
    Eur J Paediatr Neurol; 2013 Jul 01; 17(4):348-52. PubMed ID: 23391693
    [Abstract] [Full Text] [Related]

  • 11. Subependymal giant-cell astrocytoma: A surgical review in the modern era of mTOR inhibitors.
    Danassegarane G, Tinois J, Sahler Y, Aouaissia S, Riffaud L.
    Neurochirurgie; 2022 Dec 01; 68(6):627-636. PubMed ID: 35907444
    [Abstract] [Full Text] [Related]

  • 12. EFFECTS: an expanded access program of everolimus for patients with subependymal giant cell astrocytoma associated with tuberous sclerosis complex.
    Fogarasi A, De Waele L, Bartalini G, Jozwiak S, Laforgia N, Verhelst H, Petrak B, Pedespan JM, Witt O, Castellana R, Crippa S, Gislimberti G, Gyorsok Z.
    BMC Neurol; 2016 Aug 08; 16():126. PubMed ID: 27502586
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Mammalian Target of Rapamycin Inhibitor Induced Complete Remission of a Recurrent Subependymal Giant Cell Astrocytoma in a Patient Without Features of Tuberous Sclerosis Complex.
    Appalla D, Depalma A, Calderwood S.
    Pediatr Blood Cancer; 2016 Jul 08; 63(7):1276-8. PubMed ID: 26929034
    [Abstract] [Full Text] [Related]

  • 18. Retinal astrocytoma regression in tuberous sclerosis patients treated with everolimus.
    Zipori AB, Tehrani NN, Ali A.
    J AAPOS; 2018 Feb 08; 22(1):76-79. PubMed ID: 29277498
    [Abstract] [Full Text] [Related]

  • 19. Association between the growth rate of subependymal giant cell astrocytoma and age in patients with tuberous sclerosis complex.
    Tsai JD, Wei CC, Tsao TF, Hsiao YP, Tsai HJ, Yang SH, Tsai ML, Sheu JN.
    Childs Nerv Syst; 2016 Jan 08; 32(1):89-95. PubMed ID: 26552385
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.